Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia

被引:0
|
作者
A Sanchez-Aguilera
I Rattmann
D Z Drew
L U W Müller
V Summey
D M Lucas
J C Byrd
C M Croce
Y Gu
J A Cancelas
P Johnston
T Moritz
D A Williams
机构
[1] Cincinnati Children's Hospital Medical Center,Division of Experimental Hematology
[2] Children's Hospital Boston,Division of Hematology/Oncology
[3] Ohio State University,Division of Hematology & Oncology
[4] Immunology and Medical Genetics,Department of Molecular Virology
[5] Ohio State University,Department of Internal Medicine (Cancer Research)
[6] Clinical Research Program,undefined
[7] Children's Hospital Boston,undefined
[8] West German Cancer Center,undefined
[9] University of Duisburg-Essen Medical School,undefined
来源
Leukemia | 2010年 / 24卷
关键词
RhoH GTPase; chronic lymphocytic leukemia; TCL1; B cells; lymphopoiesis;
D O I
暂无
中图分类号
学科分类号
摘要
RhoH is a hematopoietic-specific, GTPase-deficient member of the Rho GTPase family that functions as a regulator of thymocyte development and T-cell receptor signaling by facilitating localization of zeta-chain-associated protein kinase 70 (ZAP70) to the immunological synapse. Here we investigated the function of RhoH in the B-cell lineage. B-cell receptor (BCR) signaling was intact in Rhoh−/− mice. Because RhoH interacts with ZAP70, which is a prognostic factor in B-cell chronic lymphocytic leukemia (CLL), we analyzed the mRNA levels of RhoH in primary human CLL cells and showed a 2.3-fold higher RhoH expression compared with normal B cells. RhoH expression in CLL positively correlated with the protein levels of ZAP70. Deletion of Rhoh in a murine model of CLL (Eμ-TCL1Tg mice) significantly delayed the accumulation of CD5+IgM+ leukemic cells in peripheral blood and the leukemic burden in the peritoneal cavity, bone marrow and spleen of Rhoh−/− mice compared with their Rhoh+/+ counterparts. Phosphorylation of AKT and ERK in response to BCR stimulation was notably decreased in Eμ-TCL1Tg;Rhoh−/− splenocytes. These data suggest that RhoH has a function in the progression of CLL in a murine model and show RhoH expression is altered in human primary CLL samples.
引用
收藏
页码:97 / 104
页数:7
相关论文
共 50 条
  • [21] Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia
    Jan A. Burger
    Current Hematologic Malignancy Reports, 2012, 7 : 26 - 33
  • [22] Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia
    Burger, Jan A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (01) : 26 - 33
  • [23] Modifying Akt Signaling in B-Cell Chronic Lymphocytic Leukemia Cells
    Hofbauer, Sebastian W.
    Pinon, Josefina D.
    Brachtl, Gabriele
    Haginger, Lucia
    Wang, Wei
    Joehrer, Karin
    Tinhofer, Ingeborg
    Hartmann, Tanja Nicole
    Greil, Richard
    CANCER RESEARCH, 2010, 70 (18) : 7336 - 7344
  • [24] Persistent polyclonal B-cell lymphocytosis – an important differential diagnosis of B-cell chronic lymphocytic leukemia
    P. Reimer
    F. Weißinger
    H.-P. Tony
    K.-H. Koniczek
    M. Wilhelm
    Annals of Hematology, 2000, 79 : 327 - 331
  • [25] Role of NFAT in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies
    Sana, Ilenia
    Mantione, Maria Elena
    Angelillo, Piera
    Muzio, Marta
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans
    Troeger, Anja
    Johnson, Amy J.
    Wood, Jenna
    Blum, William G.
    Andritsos, Leslie A.
    Byrd, John C.
    Williams, David A.
    BLOOD, 2012, 119 (20) : 4708 - 4718
  • [27] CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia
    Gong, Shunyou
    Osei, Ebenezer S.
    Kaplan, David
    Chen, Youhai H.
    Meyerson, Howard
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 1613 - 1621
  • [28] Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle?
    Tandon, Bevan
    Swerdlow, Steven H.
    Hasserjian, Robert P.
    Surti, Urvashi
    Gibson, Sarah E.
    LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3378 - 3386
  • [29] Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)
    Meacham, Philip J.
    Williams, AnnaLynn M.
    Strawderman, Myla
    Baran, Andrea M.
    Archibald, William J.
    Wallace, Danielle S.
    Tschernia, Nicholas P.
    Burack, Walter Richard
    Barr, Paul M.
    Zent, Clive S.
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1636 - 1644
  • [30] Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells
    Bruno, Silvia
    Ledda, Bernardetta
    Tenca, Claudya
    Ravera, Silvia
    Orengo, Anna Maria
    Mazzarello, Andrea Nicola
    Pesenti, Elisa
    Casciaro, Salvatore
    Racchi, Omar
    Ghiotto, Fabio
    Marini, Cecilia
    Sambuceti, Gianmario
    DeCensi, Andrea
    Fais, Franco
    ONCOTARGET, 2015, 6 (26) : 22624 - 22640